RR

Ramachandran Rajeswari

Director Director DIN 01753156
DIN 01753156 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value •••• Premium profile

About Ramachandran Rajeswari

Data last updated:

Ramachandran Rajeswari was a Director at Qed Pharmaceutical Services Private Limited (2007–2012) and Director at Zoom Clinical Trials Private Limited (2008–2012). The companies operate in Pharma and Healthcare.

DIN 01753156
Primary Designation Director
Industry Pharma
First Appointment 03 Sep 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20072007Strike Off
Zoom Clinical Trials Private Limited U85100TG2008PTC059051
Director08 May 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Qed Pharmaceutical Services Private Limited
Zoom Clinical Trials Private Limited
Premium access

Shareholding and investment profile for Ramachandran Rajeswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramachandran Rajeswari

Ramachandran Rajeswari was first appointed on 03 Sep 2007 as Director at Qed Pharmaceutical Services Private Limited. The most recent appointment on record is 08 May 2008 at Zoom Clinical Trials Private Limited.

Ramachandran Rajeswari held 2 earlier board appointments: Qed Pharmaceutical Services Private Limited (Director, 03 Sep 2007 to 27 Jun 2012); Zoom Clinical Trials Private Limited (Director, 08 May 2008 to 27 Jun 2012).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available